Next Article in Journal
The Functions of Metamorphic Metallothioneins in Zinc and Copper Metabolism
Previous Article in Journal
The Roles of Long Non-Protein-Coding RNAs in Osteo-Adipogenic Lineage Commitment
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2017, 18(6), 1241; doi:10.3390/ijms18061241

The Implication of Substance P in the Development of Tendinopathy: A Case Control Study

1
Department of Orthopedic Surgery, CHA Bundang Medical Center, CHA University, Gyeonggi-do 13496, Korea
2
Institute for Clinical Research, Department of Orthopedic Surgery, CHA Bundang Medical Center, CHA University, Gyeonggi-do 13496, Korea
3
Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Gyeonggi-do 13496, Korea
4
Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California, Los Angeles, CA 90095, USA
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Gehua Zhen
Received: 17 March 2017 / Revised: 25 May 2017 / Accepted: 6 June 2017 / Published: 9 June 2017
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
View Full-Text   |   Download PDF [6146 KB, uploaded 9 June 2017]   |  

Abstract

It was reported that substance P had beneficial effects in the healing of acute tendon injury. However, the relationship between substance P and degenerative tendinopathy development remains unclear. The purpose of this study was to determine the role of substance P in the pathogenesis of tendinopathy. Healthy and tendinopathy tendon were harvested from human and tenocytes were cultured individually. The expression levels of genes associated with tendinopathy were compared. Next, substance P was exogenously administered to the healthy tenocyte and the effect was evaluated. The results showed that tendinopathy tenocytes had higher levels of COL3A1, MMP1, COX2, SCX, ACTA2, and substance P gene expression compared to healthy tenocytes. Next, substance P treatment on the healthy tenocyte displayed similar changes to that of the tendinopathy tenocytes. These differences between the two groups were also determined by Western blot. Additionally, cells with substance P had the tendinopathy change morphologically although cellular proliferation was significantly higher compared to that of the control group. In conclusion, substance P enhanced cellular proliferation, but concomitantly increased immature collagen (type 3 collagen). Substance P plays a crucial role in tendinopathy development and could be a future therapeutic target for treatment. View Full-Text
Keywords: tendinopathy; pathogenesis; substance P; type 3 collagen tendinopathy; pathogenesis; substance P; type 3 collagen
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Han, S.-H.; Choi, W.; Song, J.; Kim, J.; Lee, S.; Choi, Y.; Byun, S.-E.; Ahn, T.; Ahn, H.; Ding, C.; Baik, L.; Ward, S.; Ting, K.; Lee, S. The Implication of Substance P in the Development of Tendinopathy: A Case Control Study. Int. J. Mol. Sci. 2017, 18, 1241.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top